Dose Calculation Accuracy of Beam Models in RadCalc for a 1.5 T MR-Linac

被引:0
|
作者
Sung, Jiwon [1 ]
Choi, Yeonho [1 ]
Kim, Jun Won [1 ]
Lee, Ho [2 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul 06273, South Korea
[2] Yonsei Univ, Coll Med, Heavy Ion Therapy Res Inst, Dept Radiat Oncol,Yonsei Canc Ctr, Seoul 03722, South Korea
关键词
MR-linac; patient-specific quality assurance; online adaptive planning; independent dose verification software; beam model; RADIOTHERAPY; VERIFICATION; FEASIBILITY; ALGORITHM;
D O I
10.3390/cancers16030526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The recent advancement to RadCalc version 7.1.4 marks a significant milestone as an independent dose verification tool tailored to encompass both mechanical and dosimetric intricacies of MR-linacs. Although previous assessments successfully validated the software's efficacy on a 0.35 T MR-linac using v7.1.4, its validation for a 1.5 T MR-linac was restricted to v6.3. This discrepancy prompted an investigation into the software's performance on a 1.5 T MR-linac due to the absence of a specific MR-linac beam-modeling protocol within RadCalc. This study's novelty lies in the rigorous evaluation of calculation accuracy utilizing diverse beam-modeling techniques for the 1.5 T MR-linac. Results of this comprehensive analysis, showcasing RadCalc's calculated doses and their alignment with expected measurements, robustly affirm its credibility and accuracy in dose calculations, particularly within the complex setting of the 1.5 T magnetic field.Abstract The purpose of this study is to evaluate RadCalc, an independent dose verification software, for patient-specific quality assurance (PSQA) in online adaptive planning with a magnetic resonance linear accelerator (MR-linac) of a 1.5 T. Version 7.1.4 of RadCalc to introduce the capability to establish a beam model that incorporates MR field characteristics. A total of six models were established, with one using manufacturer-provided data and the others differing in percentage depth dose (PDD) data sources. Overall, two models utilized PDD data from the treatment planning system (TPS), and three used commissioned PDD data from gantry angles of 0 degrees and 270 degrees. Simple tests on a virtual water phantom assessed dose-calculation accuracy, revealing percentage differences ranging from -0.5% to -20.6%. Excluding models with significant differences, clinical tests on 575 adaptive plans (prostate, liver, and breast) showed percentage differences of -0.51%, 1.12%, and 4.10%, respectively. The doses calculated using RadCalc demonstrated similar trends to those of the PSQA-based measurements. The newly released version of RadCalc enables beam modeling that considers the characteristics of the 1.5 T magnetic field. The accuracy of the software in calculating doses at 1.5 T magnetic fields has been verified, thereby making it a reliable and effective tool for PSQA in adaptive plans.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Influence and optimization strategy of the magnetic field in 1.5 T MR-linac liver stereotactic radiotherapy
    Xin Liu
    Peijun Yin
    Tengxiang Li
    Yong Yin
    Zhenjiang Li
    Radiation Oncology, 18
  • [22] Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac
    Barnes, Helen
    Alexander, Sophie
    Bower, Lorna
    Ehlers, Jakob
    Gani, Cihan
    Herbert, Trina
    Lawes, Rebekah
    Moller, Pia Krause
    Morgan, Toby
    Nowee, Marlies E.
    Smith, Gillian
    van Triest, Baukelien
    Tyagi, Neelam
    Whiteside, Lee
    McNair, Helen
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 30 : 31 - 37
  • [23] Influence and optimization strategy of the magnetic field in 1.5 T MR-linac liver stereotactic radiotherapy
    Liu, Xin
    Yin, Peijun
    Li, Tengxiang
    Yin, Yong
    Li, Zhenjiang
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [24] Dosimetric evaluation of off-axis fields and angular transmission for the 1.5 T MR-linac
    van den Dobbelsteen, M.
    Hackett, S. L.
    de Vries, J. H. W.
    van Asselen, B.
    Oolbekkink, S.
    Woodings, S. J.
    Raaymakers, B. W.
    PHYSICS IN MEDICINE AND BIOLOGY, 2022, 67 (20)
  • [25] Feasibility of using a dual isocentre technique for treating cervical cancer on the 1.5 T MR-Linac
    Chuter, Robert W.
    Brewster, Frank
    Retout, Louise
    Cree, Anthea
    Akturk, Nesrin
    Hales, Rosie
    Benson, Rebecca
    Hoskin, Peter
    McWilliam, Alan
    PHYSICS IN MEDICINE AND BIOLOGY, 2023, 68 (02)
  • [26] Surface and near-surface dose measurements at beam entry and exit in a 1.5 T MR-Linac using optically stimulated luminescence dosimeters
    Kim, Anthony
    Lim-Reinders, Stephanie
    Ahmad, Syed Bilal
    Sahgal, Arjun
    Keller, Brian M.
    PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (04)
  • [27] Robust deep learning-based forward dose calculations for VMAT on the 1.5T MR-linac
    Tsekas, G.
    Bol, G. H.
    Raaymakers, B. W.
    PHYSICS IN MEDICINE AND BIOLOGY, 2022, 67 (22)
  • [28] Feasibility of using a commercial collapsed cone dose engine for 1.5T MR-LINAC online independent dose verification
    Li, Yongbao
    Wang, Bin
    Ding, Shouliang
    Liu, Hongdong
    Liu, Biaoshui
    Xia, Yunfei
    Song, Ting
    Huang, Xiaoyan
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2020, 80 : 288 - 296
  • [29] Impact of field number and beam angle on ERE for lung stereotactic body radiotherapy with 1.5 T MR-Linac
    Ding, S.
    Liu, H.
    Wang, B.
    Li, Y.
    Li, R.
    Liu, B.
    Xia, Y.
    Huang, X.
    CANCER RADIOTHERAPIE, 2021, 25 (04): : 366 - 372
  • [30] Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients
    Lawrence, Liam S. P.
    Chan, Rachel W.
    Chen, Hanbo
    Keller, Brian
    Stewart, James
    Ruschin, Mark
    Chugh, Brige
    Campbell, Mikki
    Theriault, Aimee
    Stanisz, Greg J.
    MacKenzie, Scott
    Myrehaug, Sten
    Detsky, Jay
    Maralani, Pejman J.
    Tseng, Chia-Lin
    Czarnota, Greg J.
    Sahgal, Arjun
    Lau, Angus Z.
    RADIOTHERAPY AND ONCOLOGY, 2021, 164 : 155 - 162